Junichi Mitsuyama
Toyama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris.
Journal: Antimicrobial agents and chemotherapy
Published: October 31, 2019
The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes.
Journal: Antimicrobial agents and chemotherapy
Published: February 20, 2019
Efficacy of T-2307, a novel arylamidine, against ocular complications of disseminated candidiasis in mice.
Journal: The Journal of antimicrobial chemotherapy
Published: October 07, 2018
Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: August 21, 2018
Proposed Pharmacokinetic-Pharmacodynamic Breakpoint of Garenoxacin and Other Quinolones.
Journal: Japanese journal of infectious diseases
Published: September 12, 2017
Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: January 05, 2017
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Journal: The Journal of antimicrobial chemotherapy
Published: October 05, 2016
Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibacterial agents in Gifu and Aichi prefectures (2011-2012)
Journal: The Japanese journal of antibiotics
Published: December 03, 2015
T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2.
Journal: The Journal of antimicrobial chemotherapy
Published: August 10, 2015
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata.
Journal: The Journal of antimicrobial chemotherapy
Published: July 26, 2015
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.
Journal: Antimicrobial agents and chemotherapy
Published: December 03, 2014
Last Updated: 09/26/2026